Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

A multifaceted quality improvement project improves intraoperative redosing of surgical antimicrobial prophylaxis during pediatric surgery.

Colletti AA, Wang E, Marquez JL, Schwenk HT, Yeverino C, Sharek PJ, Caruso TJ.

Paediatr Anaesth. 2019 Apr 29. doi: 10.1111/pan.13651. [Epub ahead of print]

PMID:
31034725
2.

Feasibility and indicator outcomes using computerized clinical decision support in pediatric traumatic brain injury anesthesia care.

Colletti AA, Kiatchai T, Lyons VH, Nair BG, Grant RM, Vavilala MS.

Paediatr Anaesth. 2019 Mar;29(3):271-279. doi: 10.1111/pan.13580. Epub 2019 Feb 19.

PMID:
30609176
3.

Intraoperative antibiotic redosing compliance and the extended postoperative recovery period: Often overlooked areas that may reduce surgical site infections.

Caruso TJ, Wang EY, Colletti AA, Sharek PJ.

Paediatr Anaesth. 2019 Mar;29(3):290-291. doi: 10.1111/pan.13568. No abstract available.

PMID:
30592343
4.

Is it Possible to Significantly Modify Blood Pressure with a Combined Nutraceutical on Top of a Healthy Diet? The Results of a Pilot Clinical Trial.

Cicero AFG, Colletti A, Fogacci F, Bove M, Giovannini M, Borghi C.

High Blood Press Cardiovasc Prev. 2018 Dec;25(4):401-405. doi: 10.1007/s40292-018-0289-5. Epub 2018 Nov 23.

PMID:
30471072
5.

Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.

Cicero AFG, Colletti A, Bellentani S.

Nutrients. 2018 Aug 23;10(9). pii: E1153. doi: 10.3390/nu10091153.

6.

Commentary to: "The Effects of Coenzyme Q10 Supplementation on Blood Pressures Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials".

Cicero AFG, Fogacci F, Colletti A.

High Blood Press Cardiovasc Prev. 2018 Mar;25(1):51-52. doi: 10.1007/s40292-018-0248-1. Epub 2018 Jan 19. No abstract available.

PMID:
29352426
7.

An update on the safety of nutraceuticals and effects on lipid parameters.

Cicero AFG, Colletti A.

Expert Opin Drug Saf. 2018 Mar;17(3):303-313. doi: 10.1080/14740338.2018.1429404. Epub 2018 Jan 29. Review.

PMID:
29338456
8.

Polyphenols Effect on Circulating Lipids and Lipoproteins: From Biochemistry to Clinical Evidence.

Cicero AFG, Colletti A.

Curr Pharm Des. 2018;24(2):178-190. doi: 10.2174/1381612824666171128110408.

PMID:
29189140
9.

Short-Term Impact of a Combined Nutraceutical on Cognitive Function, Perceived Stress and Depression in Young Elderly with Cognitive Impairment: A Pilot, Double-Blind, Randomized Clinical Trial.

Cicero AF, Bove M, Colletti A, Rizzo M, Fogacci F, Giovannini M, Borghi C.

J Prev Alzheimers Dis. 2017;4(1):12-15. doi: 10.14283/jpad.2016.10.

PMID:
29188854
10.

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.

Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablík M, Wong ND, Banach M.

Nutr Rev. 2017 Sep 1;75(9):731-767. doi: 10.1093/nutrit/nux047. Review.

PMID:
28938795
11.

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.

Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablík M, Wong ND, Banach M.

Arch Med Sci. 2017 Aug;13(5):965-1005. doi: 10.5114/aoms.2017.69326. Epub 2017 Aug 4. No abstract available.

12.

Effect of apple polyphenols on vascular oxidative stress and endothelium function: a translational study.

Cicero AFG, Caliceti C, Fogacci F, Giovannini M, Calabria D, Colletti A, Veronesi M, Roda A, Borghi C.

Mol Nutr Food Res. 2017 Nov;61(11). doi: 10.1002/mnfr.201700373. Epub 2017 Sep 1.

PMID:
28755406
13.

Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach.

Cicero AFG, Fogacci F, Colletti A.

Food Funct. 2017 Jun 21;8(6):2076-2088. doi: 10.1039/c7fo00178a. Review.

PMID:
28541356
14.

Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product.

Cicero AFG, Fogacci F, Morbini M, Colletti A, Bove M, Veronesi M, Giovannini M, Borghi C.

High Blood Press Cardiovasc Prev. 2017 Sep;24(3):283-288. doi: 10.1007/s40292-017-0206-3. Epub 2017 May 23.

15.

Effects of Carotenoids on Health: Are All the Same? Results from Clinical Trials.

Cicero AFG, Colletti A.

Curr Pharm Des. 2017;23(17):2422-2427. doi: 10.2174/1381612823666170207095459. Review.

PMID:
28176669
16.

Nutraceuticals and Dietary Supplements to Improve Quality of Life and Outcomes in Heart Failure Patients.

Cicero AFG, Colletti A.

Curr Pharm Des. 2017;23(8):1265-1272. doi: 10.2174/1381612823666170124120518. Review.

PMID:
28120718
17.

Development and Feasibility of a Real-Time Clinical Decision Support System for Traumatic Brain Injury Anesthesia Care.

Kiatchai T, Colletti AA, Lyons VH, Grant RM, Vavilala MS, Nair BG.

Appl Clin Inform. 2017 Jan 25;8(1):80-96. doi: 10.4338/ACI-2016-10-RA-0164.

18.

Retargeting the management of hypercholesterolemia - focus on evolocumab.

Colletti A, Derosa G, Cicero AF.

Ther Clin Risk Manag. 2016 Sep 6;12:1365-76. doi: 10.2147/TCRM.S116679. eCollection 2016. Review.

19.

Potential role of bioactive peptides in prevention and treatment of chronic diseases: a narrative review.

Cicero AFG, Fogacci F, Colletti A.

Br J Pharmacol. 2017 Jun;174(11):1378-1394. doi: 10.1111/bph.13608. Epub 2016 Sep 29. Review.

20.
21.

Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial.

Cicero AF, Colletti A, Fogacci F, Bove M, Rosticci M, Borghi C.

High Blood Press Cardiovasc Prev. 2017 Mar;24(1):13-18. doi: 10.1007/s40292-016-0163-2. Epub 2016 Jun 23.

22.

Role of phytochemicals in the management of metabolic syndrome.

Cicero AF, Colletti A.

Phytomedicine. 2016 Oct 15;23(11):1134-44. doi: 10.1016/j.phymed.2015.11.009. Epub 2015 Dec 11. Review.

PMID:
26778479
23.

Effect of Lactotripeptides (Isoleucine-Proline-Proline/Valine-Proline-Proline) on Blood Pressure and Arterial Stiffness Changes in Subjects with Suboptimal Blood Pressure Control and Metabolic Syndrome: A Double-Blind, Randomized, Crossover Clinical Trial.

Cicero AF, Colletti A, Rosticci M, Cagnati M, Urso R, Giovannini M, Borghi C, D'Addato S.

Metab Syndr Relat Disord. 2016 Apr;14(3):161-6. doi: 10.1089/met.2015.0093. Epub 2015 Dec 18.

PMID:
26683986
24.

Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data.

Cicero AF, Colletti A.

Phytomedicine. 2016 Oct 15;23(11):1113-8. doi: 10.1016/j.phymed.2015.10.011. Epub 2015 Nov 10. Review.

PMID:
26621556
25.

Profile of evolocumab and its potential in the treatment of hyperlipidemia.

Cicero AF, Colletti A, Borghi C.

Drug Des Devel Ther. 2015 Jun 15;9:3073-82. doi: 10.2147/DDDT.S67498. eCollection 2015. Review.

26.

Nutraceuticals and Blood Pressure Control: Results from Clinical Trials and Meta-Analyses.

Cicero AF, Colletti A.

High Blood Press Cardiovasc Prev. 2015 Sep;22(3):203-13. doi: 10.1007/s40292-015-0081-8. Epub 2015 Mar 19. Review.

PMID:
25788027
27.

Species difference in glucuronidation formation kinetics with a selective mTOR inhibitor.

Berry LM, Liu J, Colletti A, Krolikowski P, Zhao Z, Teffera Y.

Drug Metab Dispos. 2014 Apr;42(4):707-17. doi: 10.1124/dmd.113.054809. Epub 2014 Jan 14.

PMID:
24423753
28.

Deletion of Abcg2 has differential effects on excretion and pharmacokinetics of probe substrates in rats.

Huang L, Be X, Tchaparian EH, Colletti AE, Roberts J, Langley M, Ling Y, Wong BK, Jin L.

J Pharmacol Exp Ther. 2012 Nov;343(2):316-24. doi: 10.1124/jpet.112.197046. Epub 2012 Aug 6.

PMID:
22869929
29.

Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitors.

Peterson EA, Boezio AA, Andrews PS, Boezio CM, Bush TL, Cheng AC, Choquette D, Coats JR, Colletti AE, Copeland KW, DuPont M, Graceffa R, Grubinska B, Kim JL, Lewis RT, Liu J, Mullady EL, Potashman MH, Romero K, Shaffer PL, Stanton MK, Stellwagen JC, Teffera Y, Yi S, Cai T, La DS.

Bioorg Med Chem Lett. 2012 Aug 1;22(15):4967-74. doi: 10.1016/j.bmcl.2012.06.033. Epub 2012 Jun 16.

PMID:
22765895
30.

Simulating ventilation distribution in heterogenous lung injury using a binary tree data structure.

Colletti AA, Amini R, Kaczka DW.

Comput Biol Med. 2011 Oct;41(10):936-45. doi: 10.1016/j.compbiomed.2011.08.004. Epub 2011 Aug 27.

31.

Discovery of triazine-benzimidazoles as selective inhibitors of mTOR.

Peterson EA, Andrews PS, Be X, Boezio AA, Bush TL, Cheng AC, Coats JR, Colletti AE, Copeland KW, DuPont M, Graceffa R, Grubinska B, Harmange JC, Kim JL, Mullady EL, Olivieri P, Schenkel LB, Stanton MK, Teffera Y, Whittington DA, Cai T, La DS.

Bioorg Med Chem Lett. 2011 Apr 1;21(7):2064-70. doi: 10.1016/j.bmcl.2011.02.007. Epub 2011 Feb 12.

PMID:
21376583
32.

Improved pharmacokinetics of AMG 517 through co-crystallization part 2: analysis of 12 carboxylic acid co-crystals.

Stanton MK, Kelly RC, Colletti A, Langley M, Munson EJ, Peterson ML, Roberts J, Wells M.

J Pharm Sci. 2011 Jul;100(7):2734-43. doi: 10.1002/jps.22502. Epub 2011 Feb 1.

PMID:
21287556
33.

Identification of quinone imine containing glutathione conjugates of diclofenac in rat bile.

Waldon DJ, Teffera Y, Colletti AE, Liu J, Zurcher D, Copeland KW, Zhao Z.

Chem Res Toxicol. 2010 Dec 20;23(12):1947-53. doi: 10.1021/tx100296v.

PMID:
21053927
34.

Bioactivation of isothiazoles: minimizing the risk of potential toxicity in drug discovery.

Teffera Y, Choquette D, Liu J, Colletti AE, Hollis LS, Lin MH, Zhao Z.

Chem Res Toxicol. 2010 Nov 15;23(11):1743-52. doi: 10.1021/tx100208k. Epub 2010 Sep 8.

PMID:
20825217
35.

Improved pharmacokinetics of AMG 517 through co-crystallization. Part 1: comparison of two acids with corresponding amide co-crystals.

Stanton MK, Kelly RC, Colletti A, Kiang YH, Langley M, Munson EJ, Peterson ML, Roberts J, Wells M.

J Pharm Sci. 2010 Sep;99(9):3769-78. doi: 10.1002/jps.22181.

PMID:
20665842
36.

Relationship between passive permeability, efflux, and predictability of clearance from in vitro metabolic intrinsic clearance.

Huang L, Berry L, Ganga S, Janosky B, Chen A, Roberts J, Colletti AE, Lin MH.

Drug Metab Dispos. 2010 Feb;38(2):223-31. doi: 10.1124/dmd.109.029066. Epub 2009 Oct 29.

PMID:
19875499
37.

Chemical reactivity of methoxy 4-o-aryl quinolines: identification of glutathione displacement products in vitro and in vivo.

Teffera Y, Colletti AE, Harmange JC, Hollis LS, Albrecht BK, Boezio AA, Liu J, Zhao Z.

Chem Res Toxicol. 2008 Nov;21(11):2216-22. doi: 10.1021/tx800307n.

PMID:
18837519
38.

Focusing microparticles in a microfluidic channel with standing surface acoustic waves (SSAW).

Shi J, Mao X, Ahmed D, Colletti A, Huang TJ.

Lab Chip. 2008 Feb;8(2):221-3. doi: 10.1039/b716321e. Epub 2007 Dec 20.

PMID:
18231658
39.

Importance of mechanistic drug metabolism studies in support of drug discovery: A case study with an N -sulfonylated dipeptide VLA-4 antagonist in rats.

Tang W, Stearns RA, Chen Q, Bleasby K, Teffera Y, Colletti A, Hafey M, Evers R, Dean DC, Magriotis PA, Lanza TJ, Lin LS, Hagmann WK, Baillie TA.

Xenobiotica. 2008 Feb;38(2):223-37. doi: 10.1080/00498250701744682 .

PMID:
18197560
40.

Identification of a novel glutathione conjugate of diclofenac by LTQ-Orbitrap.

Teffera Y, Waldon DJ, Colletti AE, Albrecht BK, Zhao Z.

Drug Metab Lett. 2008 Jan;2(1):35-40.

PMID:
19356068
41.

A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.

Gulizia M, Mangiameli S, Orazi S, Chiarandà G, Piccione G, Di Giovanni N, Colletti A, Pensabene O, Lisi F, Vasquez L, Grammatico A, Boriani G; PITAGORA Study Investigators.

Am Heart J. 2008 Jan;155(1):100-7, 107.e1. Epub 2007 Nov 26.

PMID:
18082498
42.

Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device.

Gulizia M, Mangiameli S, Orazi S, Chiarandà G, Boriani G, Piccione G, DiGiovanni N, Colletti A, Puntrello C, Butera G, Vasco C, Vaccaro I, Scardace G, Grammatico A; PITAGORA (Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias) Investigators.

Europace. 2006 Jul;8(7):465-73.

PMID:
16798758
43.

Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial.

Gulizia M, Mangiameli S, Chiarandà G, Spadola V, Di Giovanni N, Colletti A, Bulla V, Circo A, Pensabene O, Vasquez L, Vaccaro I, Grammatico A; PITAGORA Study Investigators.

Europace. 2006 Apr;8(4):302-5. Epub 2006 Feb 21.

PMID:
16627459
44.

Enantiomer ratio of MK-0767 in humans and nonclinical species.

Shen Z, Bakhtiar R, Komuro M, Awano K, Taga F, Colletti A, Hora D, Feeney W, Iliff S, Franklin RB, Vincent S.

Rapid Commun Mass Spectrom. 2005;19(9):1125-9.

PMID:
15799073
45.

Amidines as amide bond replacements in VLA-4 antagonists.

Kamenecka TM, Park YJ, Lin LS, de Laszlo S, McCauley ED, Van Riper G, Egger L, Kidambi U, Mumford RA, Tong S, Tang W, Colletti A, Teffera Y, Stearns R, MacCoss M, Schmidt JA, Hagmann WK.

Bioorg Med Chem Lett. 2004 May 3;14(9):2323-6.

PMID:
15081033
46.

Substituted 3-amino biaryl propionic acids as potent VLA-4 antagonists.

Kopka IE, Lin LS, Mumford RA, Lanza T Jr, Magriotis PA, Young D, DeLaszlo SE, MacCoss M, Mills SG, Van Riper G, McCauley E, Lyons K, Vincent S, Egger LA, Kidambi U, Stearns R, Colletti A, Teffera Y, Tong S, Owens K, Levorse D, Schmidt JA, Hagmann WK.

Bioorg Med Chem Lett. 2002 Sep 2;12(17):2415-8.

PMID:
12161146
47.

The pharmacokinetics of a thiazole benzenesulfonamide beta 3-adrenergic receptor agonist and its analogs in rats, dogs, and monkeys: improving oral bioavailability.

Stearns RA, Miller RR, Tang W, Kwei GY, Tang FS, Mathvink RJ, Naylor EM, Chitty D, Colandrea VJ, Weber AE, Colletti AE, Strauss JR, Keohane CA, Feeney WP, Iliff SA, Chiu SH.

Drug Metab Dispos. 2002 Jul;30(7):771-7.

PMID:
12065435
48.

Substituted N-(3,5-dichlorobenzenesulfonyl)-L-prolyl-phenylalanine analogues as potent VLA-4 antagonists.

Kopka IE, Young DN, Lin LS, Mumford RA, Magriotis PA, MacCoss M, Mills SG, Van Riper G, McCauley E, Egger LE, Kidambi U, Schmidt JA, Lyons K, Stearns R, Vincent S, Colletti A, Wang Z, Tong S, Wang J, Zheng S, Owens K, Levorse D, Hagmann WK.

Bioorg Med Chem Lett. 2002 Feb 25;12(4):637-40.

PMID:
11844689
49.

The discovery of acylated beta-amino acids as potent and orally bioavailable VLA-4 antagonists.

Lin LS, Kopka IE, Mumford RA, Magriotis PA, Lanza T Jr, Durette PL, Kamenecka T, Young DN, de Laszlo SE, McCauley E, Riper GV, Kidambi U, Egger LA, Tong X, Lyons K, Vincent S, Stearns R, Colletti A, Teffera Y, Fenyk-Melody J, Schmidt JA, MacCoss M, Hagmann WK.

Bioorg Med Chem Lett. 2002 Feb 25;12(4):611-4. Erratum in: Bioorg Med Chem Lett. 2002 Jun 17;12(12):1695.

PMID:
11844683
50.

The discovery of sulfonylated dipeptides as potent VLA-4 antagonists.

Hagmann WK, Durette PL, Lanza T, Kevin NJ, de Laszlo SE, Kopka IE, Young D, Magriotis PA, Li B, Lin LS, Yang G, Kamenecka T, Chang LL, Wilson J, MacCoss M, Mills SG, Van Riper G, McCauley E, Egger LA, Kidambi U, Lyons K, Vincent S, Stearns R, Colletti A, Teffera J, Tong S, Fenyk-Melody J, Owens K, Levorse D, Kim P, Schmidt JA, Mumford RA.

Bioorg Med Chem Lett. 2001 Oct 22;11(20):2709-13.

PMID:
11591507

Supplemental Content

Loading ...
Support Center